NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, has appointed neurostimulation researcher Prof. Joshua C. Brown, MD, PhD, as Chief Medical Innovation Officer, bringing a prominent academic voice in brain stimulation therapies into its leadership ranks (https://ibn.fm/zaQzM). The company is developing treatments targeting central nervous system disorders including suicidal depression and Post-Traumatic Stress Disorder (“PTSD”). […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.